Infectious bronchitis is a highly contagious viral respiratory disease of chickens caused by infectious bronchitis virus, an avian coronavirus. This disease occurs worldwide and is one of the most significant respiratory diseases affecting commercial and backyard poultry operations. Infectious bronchitis primarily affects the respiratory tract, causing characteristic gasping, coughing, and sneezing, but can also damage the reproductive system in laying hens and the kidneys in certain viral strains. The economic impact of infectious bronchitis is substantial, resulting from mortality in young birds, reduced growth rates, decreased egg production and quality in layers, and increased susceptibility to secondary bacterial infections.
The causative agent, infectious bronchitis virus, belongs to the family Coronaviridae and is characterized by its rapid mutation rate and the existence of numerous serotypes and variants worldwide. This genetic variability presents significant challenges for disease control, as immunity to one strain may not provide protection against antigenically different strains. The virus spreads primarily through respiratory aerosols and can travel considerable distances on air currents, making containment difficult once infection is introduced to an area. Contaminated equipment, clothing, and materials can also serve as fomites for mechanical transmission between flocks. Understanding the transmission dynamics and strain variability of infectious bronchitis virus is essential for implementing effective prevention strategies.
The impact of infectious bronchitis on affected flocks varies depending on the age of the birds, the specific viral strain involved, and the presence of complicating factors. In young chicks, mortality rates can be significant, particularly when nephropathogenic kidney-damaging strains are involved or when secondary bacterial infections develop. In laying hens, the most prominent effects are on egg production and quality, with sudden drops in production, misshapen shells, watery albumin, and other egg abnormalities. Some strains cause permanent damage to the developing reproductive tract in young pullets, resulting in birds that never achieve normal production. The respiratory damage predisposes birds to secondary infections with Mycoplasma and bacteria, which can worsen outcomes significantly.
There is no specific antiviral treatment for infectious bronchitis, and management of outbreaks focuses on supportive care, control of secondary infections, and prevention of spread. Vaccination is widely practiced in commercial operations and is increasingly recommended for backyard flocks in areas where the disease is prevalent. Due to the antigenic variability of the virus, vaccine selection should be based on the strains circulating in the local area. Early recognition of respiratory disease signs and prompt implementation of supportive measures can significantly reduce losses. Consultation with a poultry veterinarian is essential for accurate diagnosis, appropriate vaccine selection, and development of comprehensive control strategies for infectious bronchitis.
